A phase III, single-blind, randomized comparative clinical trial of efficacy and safety of remimazolam versus propofol

Trial Profile

A phase III, single-blind, randomized comparative clinical trial of efficacy and safety of remimazolam versus propofol

Planning
Phase of Trial: Phase III

Latest Information Update: 23 Nov 2017

At a glance

  • Drugs Remimazolam (Primary) ; Propofol
  • Indications General anaesthesia
  • Focus Registrational; Therapeutic Use
  • Sponsors Hana Pharm
  • Most Recent Events

    • 23 Nov 2017 According to a PAION media release, the trial will be conducted at 12 sites including Seoul National University Hospital.
    • 16 Mar 2017 According to a PAION media release, this trial is expected to start in 2018.
    • 04 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top